Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21353695 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
Condition: Bone Metastases
Interventions: Drug: zoledronic acid;   Biological: denosumab

Indicates status has not been verified in more than two years